SCHEMBL19794315

SCHEMBL19794315

CCOC1C(OCC)C1OCC

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL802751 0.78
SCHEMBL13747439 0.78
SCHEMBL18755366 0.78
SCHEMBL17053355 0.78 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2
SCHEMBL18755373 0.78
SCHEMBL14329784 0.78
SCHEMBL4355915 0.78 GBA1 (0.42) ALDH1A1SMN1; SMN2
SCHEMBL8964398 0.76
SCHEMBL2627862 0.75 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2
SCHEMBL15926062 0.75 GBA1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 ALDH1A1 2597/4885SMN1; SMN2 4144/4885TSHR 4071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.